Feb 26,2021 01:03 PM
The drug maker on Friday announced the launch of brivaracetam tablets under brand Brecita in India.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||614.20||49.67||147,415.14||555.55||0.65||3,366.01||106.10|
|Divis Laboratories Ltd||3,516.90||50.21||93,326.81||461.24||0.46||1,656.48||313.47|
|Dr Reddys Laboratories Ltd||4,404.70||30.82||73,275.36||443.70||0.57||3,397.50||979.36|
|Aurobindo Pharma Ltd||885.90||17.42||51,958.11||740.51||0.34||3,701.14||246.88|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
No Company Summary found
Reports by Natco-Pharma-Ltd-share-price
Mar 03, 2021 05:21 AM
The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.
11 Feb 2021
22 Feb 2021
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More
11 Feb 2021
03 Feb 2021
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
12 Nov 2020
24 Nov 2020
Unaudited Financial Results for the Quarter and Half year ended 30th September, 2020... More